Physician profile
William Yi
NPI 1861628729
$19,083.46
in general payments reported to CMS, 2019-2025
15 companies · $756 in 2025
The $756 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $7,169 · 2020: $60.88 · 2021: $1,417 · 2023: $4,922 · 2024: $4,758 · 2025: $756.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $5,000 · Travel and Lodging: $4,377 · Food and Beverage: $1,050 · Gift: $8.74.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $5,000.00 |
| Travel and Lodging | $4,377.20 |
| Food and Beverage | $1,050.16 |
| Gift | $8.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $17,211.03 | 2019-2025 | Da Vinci Surgical System, Davinci Xi |
| Stryker Corporation | $1,085.03 | 2023-2025 | 1788, 1688 |
| Medtronic, INC. | $288.59 | 2023-2024 | Ligasure |
| Medical Device Business Services, INC. | $246.08 | 2019 | |
| Conmed Corporation | $40.00 | 2019 | |
| Akorn, INC. | $36.52 | 2020 | |
| Acera Surgical, INC. | $33.76 | 2019 | |
| Abbvie INC. | $27.18 | 2025 | |
| Smith+Nephew, INC. | $22.18 | 2019 | |
| Acell, INC. | $18.68 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $18.41 | 2024 | Gattex |
| Osiris Therapeutics INC. | $17.33 | 2019 | |
| Novo Nordisk INC | $15.38 | 2025 | |
| W. L. Gore & Associates, INC. | $14.57 | 2019 | |
| Bolder Surgical LLC | $8.72 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Yi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.